Viewing Study NCT01482156


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2025-12-25 @ 9:10 PM
Study NCT ID: NCT01482156
Status: COMPLETED
Last Update Posted: 2020-12-21
First Post: 2011-09-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-01
Start Date Type: None
Primary Completion Date: 2015-02
Primary Completion Date Type: ACTUAL
Completion Date: 2015-02
Completion Date Type: ACTUAL
First Submit Date: 2011-09-26
First Submit QC Date: None
Study First Post Date: 2011-11-30
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-12-17
Last Update Post Date: 2020-12-21
Last Update Post Date Type: ACTUAL